Preoperative chemotherapy for patients with bowel cancer reduces risk of disease returning

British scientists say that providing patients with early-stage bowel cancer chemotherapy before and after surgery can reduce the risk of the disease returning by 28%. The study assessed outcomes from a clinical trial, and is published in the Journal of Clinical Oncology.

Guardian